Bioventix (LON:BVXP) Shares Pass Below Two Hundred Day Moving Average – Here’s Why

Bioventix PLC (LON:BVXP – Get Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 1,690.45 and traded as low as GBX 1,600. Bioventix shares last traded at GBX 1,700, with a volume of 2,422 shares.

Bioventix Price Performance

The firm has a market capitalization of £88.83 million, a PE ratio of 12.10 and a beta of 0.55. The stock has a 50-day moving average price of GBX 1,682.18 and a 200 day moving average price of GBX 1,690.45.

Get Bioventix alerts:

Bioventix (LON:BVXP – Get Free Report) last announced its earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 earnings per share (EPS) for the quarter. The firm had revenue of GBX 615.88 billion for the quarter. Bioventix had a return on equity of 65.83% and a net margin of 59.30%. As a group, equities analysts predict that Bioventix PLC will post 166.3066955 earnings per share for the current fiscal year.

Insider Buying and Selling at Bioventix

In related news, insider Peter John Harrison bought 1,065 shares of the business’s stock in a transaction dated Wednesday, April 8th. The stock was acquired at an average price of GBX 1,849 per share, with a total value of £19,691.85. Also, insider Ian James Nicholson purchased 1,000 shares of Bioventix stock in a transaction that occurred on Friday, April 10th. The shares were bought at an average price of GBX 1,848 per share, with a total value of £18,480. Insiders have purchased a total of 2,665 shares of company stock valued at $4,888,665 over the last ninety days. Corporate insiders own 6.22% of the company’s stock.

Bioventix Company Profile

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Featured Stories

• Five stocks we like better than Bioventix
• AirJoule Unveils Prime System, Clearing Path to Commercialization
• Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
• Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
• Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.